AU2003265639A1 - Process for producing metered dose inhaler formulations - Google Patents

Process for producing metered dose inhaler formulations

Info

Publication number
AU2003265639A1
AU2003265639A1 AU2003265639A AU2003265639A AU2003265639A1 AU 2003265639 A1 AU2003265639 A1 AU 2003265639A1 AU 2003265639 A AU2003265639 A AU 2003265639A AU 2003265639 A AU2003265639 A AU 2003265639A AU 2003265639 A1 AU2003265639 A1 AU 2003265639A1
Authority
AU
Australia
Prior art keywords
metered dose
dose inhaler
container
suspension
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003265639A
Other languages
English (en)
Inventor
Julianne Berry
Saeed Chaudhry
Joel A. Sequeira
Stefan A. Sharpe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme LLC
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of AU2003265639A1 publication Critical patent/AU2003265639A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B31/00—Packaging articles or materials under special atmospheric or gaseous conditions; Adding propellants to aerosol containers
    • B65B31/003—Adding propellants in fluid form to aerosol containers
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B3/00—Packaging plastic material, semiliquids, liquids or mixed solids and liquids, in individual containers or receptacles, e.g. bags, sacks, boxes, cartons, cans, or jars
    • B65B3/003—Filling medical containers such as ampoules, vials, syringes or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/04—Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0065—Inhalators with dosage or measuring devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Mechanical Engineering (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
AU2003265639A 2002-08-27 2003-08-26 Process for producing metered dose inhaler formulations Abandoned AU2003265639A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US40612702P 2002-08-27 2002-08-27
US60/406,127 2002-08-27
US42243602P 2002-10-30 2002-10-30
US60/422,436 2002-10-30
PCT/US2003/026512 WO2004020289A1 (en) 2002-08-27 2003-08-26 Process for producing metered dose inhaler formulations

Publications (1)

Publication Number Publication Date
AU2003265639A1 true AU2003265639A1 (en) 2004-03-19

Family

ID=31981380

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003265639A Abandoned AU2003265639A1 (en) 2002-08-27 2003-08-26 Process for producing metered dose inhaler formulations

Country Status (14)

Country Link
US (3) US20040042973A1 (https=)
EP (2) EP1878664B1 (https=)
JP (3) JP4679901B2 (https=)
AT (2) ATE503687T1 (https=)
AU (1) AU2003265639A1 (https=)
CA (1) CA2495875C (https=)
CY (1) CY1107376T1 (https=)
DE (2) DE60318727T2 (https=)
DK (1) DK1542904T3 (https=)
ES (1) ES2297262T3 (https=)
MX (1) MXPA05002248A (https=)
PT (1) PT1542904E (https=)
SI (1) SI1542904T1 (https=)
WO (1) WO2004020289A1 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0207906D0 (en) 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and mometasone aerosol formulations
ES2388537T3 (es) * 2002-08-23 2012-10-16 Merck Sharp & Dohme Corp. Inhalador dosificador que contiene una formulación en suspensión de aerosol
CN1870976A (zh) * 2003-10-20 2006-11-29 先灵公司 药物组合物
SE0401408D0 (sv) * 2004-06-02 2004-06-02 Astrazeneca Ab Diameter measuring device
DE602005009012D1 (de) * 2004-10-12 2008-09-25 Generics Uk Ltd Rmulierungen, worin die partikel durch präzipition in einem aerosolbehälter gebildet werden
US20070099883A1 (en) * 2005-10-07 2007-05-03 Cheryl Lynn Calis Anhydrous mometasone furoate formulation
WO2008047149A1 (en) * 2006-10-19 2008-04-24 Cipla Limited Pharmaceutical compositions and nasal spray incorporating anhydrous mometasone furoate
US20080253970A1 (en) * 2007-02-09 2008-10-16 Schering Corporation Stable Pharmaceutical Drug Products
BRPI0721256A2 (pt) 2007-02-09 2013-03-12 Schering Corp aerossàis de fÁrmaco farmacÊuticos estÁveis
HUE027718T2 (en) 2009-05-12 2016-10-28 Galenica Ab Oil-in-water emulsion containing mometasone and propylene glycol
US20120128736A1 (en) * 2009-05-12 2012-05-24 Galenica Ab Oil-in-water emulsion of mometasone
AU2015200276B2 (en) * 2010-02-10 2016-01-21 Astrazeneca Uk Limited A filled canister for an inhaler
CN102858640B (zh) * 2010-02-10 2015-12-09 阿斯利康英国有限公司 提供用于吸入器的填充罐的方法
CN107626019A (zh) * 2016-07-18 2018-01-26 卓效医疗有限公司 手持式喷雾器
CN107951893B (zh) * 2016-10-18 2022-04-26 天津金耀集团有限公司 一种糠酸莫米松粉吸入剂组合物

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3592319A (en) * 1968-10-28 1971-07-13 Roy S Rousseau Article feed control
US3835898A (en) * 1972-11-13 1974-09-17 Kartridg Pak Co Remotely adjustable filling head
US4793461A (en) * 1987-02-26 1988-12-27 The Kartridg Pak Co. Container feed apparatus
US5143260A (en) * 1990-06-05 1992-09-01 Nozone Dispenser Systems, Inc. Aerosol adapter clamp and power system
US5182097A (en) * 1991-02-14 1993-01-26 Virginia Commonwealth University Formulations for delivery of drugs by metered dose inhalers with reduced or no chlorofluorocarbon content
ATE339952T1 (de) * 1991-06-10 2006-10-15 Schering Corp Fluorchlorkohlenwasserstofffreie aerosolformulierungen
CA2111002C (en) * 1991-06-10 2000-08-22 Julianne Fassberg Non-chlorofluorocarbon aerosol formulations
US5275212A (en) * 1993-02-24 1994-01-04 Minnesota Mining And Manufacturing Company Aerosol filling method
GB9612297D0 (en) * 1996-06-11 1996-08-14 Minnesota Mining & Mfg Medicinal aerosol formulations
US5698161A (en) 1996-08-26 1997-12-16 Michigan Critical Care Consultants, Inc. Hollow, multi-dimensional array membrane
CZ294064B6 (cs) * 1996-08-29 2004-09-15 Schering Corporation Aerosolový suspenzní přípravek mometazonfuroátu bez chlorfluorovaných uhlovodíků
US6068832A (en) * 1996-08-29 2000-05-30 Schering Corporation Chlorofluorocarbon-free mometasone furoate aerosol formulations
US20060165606A1 (en) * 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6004537A (en) * 1998-12-18 1999-12-21 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
GB9904919D0 (en) * 1999-03-03 1999-04-28 Novartis Ag Organic compounds
AU2206801A (en) * 1999-12-24 2001-07-09 Alan Leslie Cripps Pharmaceutical aerosol formulation of salmeterol and fluticasone propionate
AU2001278115A1 (en) 2000-08-04 2002-02-18 Longwood Pharmaceutical Research, Inc. Formulations of mometasone and a bronchodilator for pulmonary administration
ITMI20010428A1 (it) * 2001-03-02 2002-09-02 Chemo Breath S A Composizioni ad uso inalatorio a base di formoterolo
AR036358A1 (es) * 2001-08-28 2004-09-01 Schering Corp Un inhalador de dosis medidas que contiene una formulacion de suspension en aerosol para inhalacion, un proceso para la produccion de la formulacion, el producto y el uso de una formulacion para la manufactura de un medicamento de asma
GB0207906D0 (en) * 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and mometasone aerosol formulations
ES2388537T3 (es) * 2002-08-23 2012-10-16 Merck Sharp & Dohme Corp. Inhalador dosificador que contiene una formulación en suspensión de aerosol
CN1870976A (zh) * 2003-10-20 2006-11-29 先灵公司 药物组合物
CA2641616A1 (en) * 2006-02-09 2007-08-23 Schering Corporation Pharmaceutical formulations
US20080253970A1 (en) * 2007-02-09 2008-10-16 Schering Corporation Stable Pharmaceutical Drug Products

Also Published As

Publication number Publication date
SI1542904T1 (sl) 2008-06-30
JP4679901B2 (ja) 2011-05-11
EP1542904B1 (en) 2008-01-16
EP1542904A1 (en) 2005-06-22
JP2005537095A (ja) 2005-12-08
DK1542904T3 (da) 2008-04-21
CA2495875C (en) 2010-06-22
EP1878664B1 (en) 2011-03-30
ATE503687T1 (de) 2011-04-15
US20130068218A1 (en) 2013-03-21
MXPA05002248A (es) 2005-06-08
US20040042973A1 (en) 2004-03-04
PT1542904E (pt) 2008-03-24
CY1107376T1 (el) 2012-12-19
CA2495875A1 (en) 2004-03-11
DE60336602D1 (de) 2011-05-12
DE60318727T2 (de) 2009-01-08
US20080066744A1 (en) 2008-03-20
ES2297262T3 (es) 2008-05-01
ATE384001T1 (de) 2008-02-15
JP2011046726A (ja) 2011-03-10
EP1878664A1 (en) 2008-01-16
JP2006305390A (ja) 2006-11-09
DE60318727D1 (de) 2008-03-06
WO2004020289A1 (en) 2004-03-11

Similar Documents

Publication Publication Date Title
CY1107376T1 (el) Μεθοδος παρασκευης συνταγοποιησεων για συσκευη εισπνοης μετρημενης δοσης
FI2515855T6 (fi) Yhdistelmähoito keuhkoahtaumatautia (copd) varten
WO2004112702A3 (en) Low dose pharmaceutical powders for inhalation
UA89751C2 (ru) Состав, который содержит сульфат альбутерола и бромид ипратропия, способ его получения и ингалятор
CA2447510A1 (en) Fluorocarbon aerosol medicaments
WO2004041340A3 (en) Increased dosage metered dose inhaler
CA2567517A1 (en) System, method, and computer program product for handling, mixing, dispensing, and injecting radiopharmaceutical agents
WO2009002084A3 (en) Method for preparing rapidly disintegrating formulation for oral administration and apparatus for preparing and packing the same
NZ737862A (en) High-concentration monoclonal antibody formulations
CA2353959A1 (en) A medicinal aerosol formulation
BR0009604A (pt) Formulações de goma de mascar sobre-revestidas
CN1228712A (zh) 水基药物组合物
MX335944B (es) Composiciones que comprenden sulfato de salbutamol.
AR039317A1 (es) Proceso para la preparacion de una suspension esteril de particulas de dipropionato de beclometasona para administracion por inhalacion
WO2002024261A3 (en) Shock wave aerosolization apparatus and method
MX2014004364A (es) Composiciones que comprenden sulfato de salbutamol.
US20110240504A1 (en) Method and apparatus for packaging and dispensing pharmaceuticals
TW200503922A (en) Densification of aerated powders using positive pressure
US20160220465A1 (en) Minoxidil formulations
MXPA05006528A (es) Proceso para preparar formulaciones farmaceuticas en combinacion utilizando fluidos supercriticos.
JP6018438B2 (ja) 滴下式エアゾール製品
JPH11236306A (ja) 噴霧用組成物およびそれを用いてなる噴霧製品
BRPI0607990A2 (pt) formulação de um aerossol farmacêutico para inaladores dosimetrados pressurizados contendo um agente seqüestrante, uso do agente sequestrante, inalador de dosimetrado pressurizado e método de preenchimento do inalador de aerossol
CN1385165A (zh) 利巴韦林雾化吸入溶液
KR20200111754A (ko) 이산화 염소 발생 에어졸

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase